Evogene (EVGN) Shares Outstanding (2011 - 2026)

Evogene has disclosed Shares Outstanding (Entity) across 15 years of filings, most recently posting $8.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 33.83% year-over-year to $8.7 million; the TTM figure through Dec 2025 stood at $8.7 million (up 33.83% YoY), while the FY2025 annual figure was $8.7 million, up 33.83% from the prior year.
• Shares Outstanding (Entity) came in at $8.7 million for Q4 2025 at Evogene, up from $6.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $8.7 million in Q4 2025 to a low of $4.1 million in Q4 2021.
• Average Shares Outstanding (Entity) over 5 years is $5.7 million, with a median of $5.1 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) soared 46.21% in 2021 and advanced 0.22% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $4.1 million in 2021, then gained by 0.22% to $4.1 million in 2022, then increased by 22.6% to $5.1 million in 2023, then increased by 28.79% to $6.5 million in 2024, then soared by 33.83% to $8.7 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $8.7 million in Q4 2025, $6.5 million in Q4 2024, and $5.1 million in Q4 2023.